Priapism in Chronic Myeloid Leukemia: A Rare Case
DOI:
https://doi.org/10.35335/midwifery.v10i4.678Keywords:
Chronic Myeloid Leukemia, Priapism, Peripheral bloodAbstract
Causes of CML not clear with a important role from gen and environment factors, such as pesticide use. Priapism in CML around 5%. The report from this case is a man 40 years old with erection complaint in 4 days, patient feel a painful and weak. Patient as a farmer. In the physical check. There is anemic palpebral conjunctiva, hepatosplenomegaly, erection. In the laboratory result, Hb 4,3, Leukocyte 354.300, peripheral blood picture suggests chronic hematological malignancy myeloid series, BMP showed chronic phase CML, cavernous sinus blood gas analysis pH 7.567 pCO2 33.7 HCO3 31.0. In the first control Hb 8.7 Leukocyte 3000, BCR ABL detected. In the second control, leukocyte 22.500. Then, patient is aspirated and winter procedure for priapism management. Patient get transfuse PRC leukodeplected with the Hb target 10, Terbutaline tab 5 mg/12 hours, Allopurinol tab 300 mg/24 hours, hydroxyurea tab 1.500 mg/24-night hours. Giving Tyrosine Kinase inhibitor was delayed when controlling time because there is leukopenia so the blood should be monitor in two weeks routinely, then, in the second control, patient given nilotinib 1x150 mg and hydroxyurea was stopped. The conclusion is patient with priapism is clinical from leukocytosis in CML. Monitoring blood routinely is more important to assess the response to therapy, in addition, it is necessary to carry out a cytogenic and molecular evaluation.
Downloads
References
Basuki, P. B. (2007). Dasar – dasar urologi (kedua). Jakarta: Sagung Seto.
Bintoro, S. U. Y. (2019). CHRONIC MYELOID LEUKEMIA: Perkembangan Baru dalam Tata Laksana dan Implikasi Terhadap Ketahanan Hidup. Surabaya: Airlangga University Press.
Breyer, B. N., & McAninch, J. W. (2008). Disorders of the penis & male urethra. In Smith General Urology (17th ed.). Lange.
Hochhaus, A., Saussele, S., Rosti, G., Mahon, F.-X., Janssen, J. J. W. M., Hjorth-Hansen, H., … Buske, C. (2017). Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 28(4), iv41–iv51. https://doi.org/10.1093/annonc/mdx219
Hochhaus, Andreas, & Kantarjian, H. (2013). The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients. Journal of Cancer Research and Clinical Oncology, 139(12), 1971–1984. https://doi.org/10.1007/s00432-013-1488-z
Hughes, T. P., Lipton, J. H., Spector, N., Cervantes, F., Pasquini, R., Clementino, N. C. D., … Leber, B. (2014). Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib. Blood, 124(5), 729–736. https://doi.org/10.1182/blood-2013-12-544015
López, M. A., & MartÃÂÂnez, A. G. de J. (2004). [Priapism as an initial presentation of chronic myeloid leukaemia]. Actas Urol Esp, 28(5), 387–389.
M, E., DC, B., SRC, M., & RP, D. (2015). Priapism as a Rare Presentation of Chronic Myelogenous Leukemia. 53(4), 1–5.
Network, N. C. C. (2018). Chronic Myeloid Leukemia (Version 4). Retrieved from NCCN guidelines for the management of CML website: https://www.nccn.org/professionals/physician_gls/pdf/cml. pdf
Rohrbacher, M., & Hasford, J. (2009). Epidemiology of chronic myeloid leukaemia (CML). Best Practice & Research Clinical Haematology, 22(3), 295–302. https://doi.org/10.1016/j.beha.2009.07.007
Saultz, J., & Garzon, R. (2016). Acute Myeloid Leukemia: A Concise Review. Journal of Clinical Medicine, 5(3), 33. https://doi.org/10.3390/jcm5030033
Sawyers, C. L. (1999). Chronic Myeloid Leukemia. New England Journal of Medicine, 340(17), 1330–1340. https://doi.org/10.1056/NEJM199904293401706
Shaeer, O. K. Z. M., Shaeer, K. Z. M., AbdelRahman, I. F. S., Elâ€ÂÂHaddad, M. S., & Selim, O. M. (2015). Priapism as a Result of Chronic Myeloid Leukemia: Case Report, Pathology, and Review of the Literature. The Journal of Sexual Medicine, 12(3), 827–834. https://doi.org/10.1111/jsm.12812
Sudoyo, A. (2009). Buku Ajar Ilmu Penyakit Dalam (V). Jakarta: Intera Publishing.
Varım, C., Karacaer, C., Çekdemir, D., & Ergenc, H. (2015). Chronic myeloid leukemia presented with priapism: Effective management with prompt leukapheresis. Nigerian Journal of Clinical Practice, 18(6), 828. https://doi.org/10.4103/1119-3077.163282
Yeung, D. T., & Mauro, M. J. (2014). Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Hematology, 2014(1), 240–243. https://doi.org/10.1182/asheducation-2014.1.240


